Sunday, September 13, 2026

Energy & Environment

2 articles

AI Bird Detection System Cuts Wind Turbine Deaths 95% Across Global Installations

AI Bird Detection System Cuts Wind Turbine Deaths 95% Across Global Installations

Boulder Imaging's IdentiFlight AI system reduces bird mortality at wind farms by over 95% while limiting energy losses to under 1%, addressing a key regulatory barrier to wind expansion worldwide. The computer vision platform detects protected species from 1.5 kilometers away, automatically curtailing turbines only when necessary. The technology's commercial deployment follows enterprise investment from Lime Rock New Energy.

LM Salvado
Metallurgical Coal Faces 40% Demand Drop by 2040 as Hydrogen Steelmaking Spreads Globally

Metallurgical Coal Faces 40% Demand Drop by 2040 as Hydrogen Steelmaking Spreads Globally

Alpha Metallurgical Resources confronts 70% confidence climate transition risk as steel producers in Germany, Sweden, and China shift to hydrogen-based production that eliminates metallurgical coal use. Met coal prices fell 50% from $615 per ton in Q1 2022 to $310 in Q4 2025. EU carbon border mechanisms create €50-75 per ton cost advantage for hydrogen steel over traditional blast furnace methods.

ViaNews Editorial Team
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Keeps Flowing as Enterprise Adoption and Government Contracts Validate the Bet
A late-August surge of nine-figure funding rounds (Socure, Stability AI, Generalist AI, Gatik, Regent Craft, Emerald AI, Owner) shows venture capital still pouring into AI infrastructure, identity/fintech, and autonomy, even as public-market sentiment stays jumpy — Palantir's stock fell 6% the same week it landed the Army's TITAN contract. UiPath's raised guidance and strong Q2 results, alongside efficiency breakthroughs like Multiverse Computing's model compression, point to real enterprise monetization catching up to the funding hype.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
JPMorgan Chase & Co.
Both facts record the same attribute (net_income) for JPMorgan Chase & Co. in the identical fiscal period (Q1 2026) and observation date (2026-03-31), but report values that differ by approximately 1 billion times: $16,494,000,000 vs $16.49. These cannot both be true simultaneously. The discrepancy suggests either a unit mismatch (e.g., one is total net income, the other earnings per share mislabeled as net_income), a decimal point error, or data entry corruption. For the same entity, attribute, and time period, only one value can be correct.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,280 source documents archived
Query this data → isubstrate.com